July 2025 - Seleniumfacts.com

Sex differences in selenium metabolism played a considerable role in the heart health outcomes of the KiSel-10 study. In that randomized controlled trial, the researchers administered 200 mcg/day selenium and 200 mg/day Coenzyme Q10 or matching placebos to elderly Swedish study participants with low selenium status. The combined supplementation significantly improved heart function and reduced cardiovascular mortality [Alehagen 2013].

Prof Urban Alehagen selenium researcher — Pictured lecturing, Prof. Urban Alehagen is the chief researcher and the lead author on many of the KiSel-10 Study publications. His work has shown the heart health benefits of selenium supplementation in elderly individuals low in selenium.

Note that, on average, the baseline selenium status in the KiSel-10 study participants was at a deficiency level, 67.1 mcg/L. The elderly citizens’ CoQ10 level was only borderline satisfactory, 0.82 mg/L at the study start. Prof. Urban Alehagen and the KiSel-10 research team knew that a low selenium intakes and an aging-related decline in CoQ10 bio-synthesis are associated with increased risk of cardiovascular disease [Alehagen 2013; Alehagen 2020]. read more

All-cause mortality, cancer mortality, and cardiovascular disease mortality are all three significantly associated with selenium status in the blood. Higher selenium status correlates with lower mortality risk. In particular, the inverse relationship with all-cause mortality was strong among different study populations in different countries and in different study regions. The inverse relationship was strong with different selenium measurement methods, with different study recruitment years, and with different study sizes and study follow-up lengths [Cui 2025].

Grave of Edith Piaf in the Pere Lachaise cemetery — **Nearly a billion people in the world live in selenium-poor regions. Low selenium status in humans is strongly associated with an increased mortality risk.**

These are the conclusions from a systematic review and meta-analysis of 20 observational studies that enrolled 67,534 study participants. The studies included 17 studies of all-cause mortality, 7 studies of cancer mortality, and 9 studies of cardiovascular disease mortality. The review shows that a concentration increase of one standard deviation in serum or plasma selenium biomarkers was associated with 13% lower all-cause mortality, 15% lower cancer mortality, and 11% lower cardiovascular mortality [Cui 2025]. read more

Milestones in early selenium research

1817 Swedish chemist Jöns Jakob Berzelius discovers selenium

1957 Biochemist Klaus Schwarz shows that selenium in microscopic amounts has a vital importance for mammalian health

1969 Professor J.T. Rotruck discovers that selenium has a biochemical role as a component of the antioxidant enzyme glutathione peroxidase

1969 Professors R.J. Shamberger and D.V. Frost report a possible protective effect of selenium against cancer in humans

1973 Professor J.T. Rotruck identifies the enzyme glutathione peroxidase as a selenium-dependent protein

1977 Professor G.N. Schrauzer publishes cancer mortality correlation studies showing an inverse correlation between dietary intakes of selenium and cancer mortality in 27 countries

1988 Professor G.Q Yang summarizes the lessons learned about the selenium-related endemic diseases Keshan disease and Kashin-Beck disease and about the importance of adequate daily selenium intakes

1989 Professor G.G. Duthie publishes evidence for a role of selenium in the prevention of cardiovascular disease

1993 Researcher W.J. Blot publishes the results of the Nutrition Intervention Trials in Linxian, China, showing that supplementation with a combination of selenium and other antioxidants reduces the risk of cancer

1994 Professor G.N. Schrauzer publishes evidence that selenium is important in the maintenance and therapy of HIV-infected patients

1996 Professor Larry Clark publishes the results of a randomized controlled trial – the Nutritional Prevention of Cancer study -- that shows selenium's cancer-protective effects on colon cancer, lung cancer, and prostate cancer

1997 Professor G.F. Combs summarizes the evidence for the protective effects of selenium against cancer

1999 Professor J.E. Oldfield publishes his Selenium World Atlas, mapping areas of selenium deficiency around the world

2000 Researcher O.A. Levander publishes evidence showing an anti-viral effect of selenium

2002 Researcher R. Gärtner shows that supplementation with selenium reduces inflammation in patients with autoimmune thyroiditis

2002 Researcher Margaret Rayman presents the arguments for increasing selenium intakes to realize selenium’s antioxidant and anti-viral and anti-inflammatory effects as well as selenium’s enhancement of immune function and reproductive success.

Month: July 2025

Sex Differences in Selenium Metabolism

Selenium Status and Mortality Risk